去年，Penumbra Inc表現最佳的業務類別Thrombectomy的營收達到947.92M美元。United States的營收貢獻最高，去年達到1.09B美元。最近一個季度，截至2026-06-30，Penumbra Inc表現最佳的業務類別Thrombectomy的營收達到258.98M美元。United States的營收貢獻最高，達到305.44M美元。

業務

營業收入

佔比

年報

年報

單季報

Thrombectomy

Embolization and Access

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Thrombectomy

947.92M(67.53%)

815.48M(68.26%)

677.34M(63.99%)

499.39M(58.95%)

408.88M(54.69%)

267.78M(47.78%)

215.72M(39.41%)

Embolization and Access

455.75M(32.47%)

379.14M(31.74%)

381.18M(36.01%)

347.74M(41.05%)

338.71M(45.31%)

292.63M(52.22%)

331.69M(60.59%)

地區

營業收入

佔比

年報

年報

單季報

United States

International

Japan

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

United States

1.09B(77.78%)

902.07M(75.51%)

757.15M(71.53%)

591.72M(69.85%)

527.79M(70.60%)

400.27M(71.42%)

355.22M(64.89%)

290.72M(65.34%)

219.17M(65.67%)

176.10M(66.88%)

127.31M(68.41%)

82.97M(66.10%)

58.30M(65.62%)

International

311.90M(22.22%)

292.55M(24.49%)

301.37M(28.47%)

255.42M(30.15%)

219.80M(29.40%)

160.14M(28.58%)

149.66M(27.34%)

112.42M(25.27%)

80.80M(24.21%)

56.93M(21.62%)

39.77M(21.37%)

27.85M(22.19%)

17.88M(20.12%)

Japan

--(--)

42.52M(7.77%)

41.80M(9.40%)

33.79M(10.12%)

30.28M(11.50%)

19.02M(10.22%)

14.70M(11.71%)

12.67M(14.26%)